Q4 2025 net product revenue for ZORYVE® (roflumilast) was $127.5 million, an 84% increase compared to Q4 2024, and a 29% increase compared to Q3 2025Full year 2025 net product ...

Royalty Pharma’s valuation remains attractive, supported by sector momentum and sustained capital returns. Click here to know ...

Richard R. Redfern, M.S., C.P.G. No. 10717, an independent Consulting Geologist for Fairchild and a "qualified person" as defined in NI 43-101, has reviewed and approved the scientific and technical ...

Some Roman Catholic parishes are reporting rising membership for the first time in years, and it appears a new generation of worshippers is starting to fill the pews.

Panther Minerals Inc. is a North American mineral acquisition and exploration company focused on the development of quality precious and base metal properties that are drill-ready with high-upside and ...